Prime Medicine Files 8-K
Ticker: PRME · Form: 8-K · Filed: Mar 18, 2025 · CIK: 1894562
| Field | Detail |
|---|---|
| Company | Prime Medicine, Inc. (PRME) |
| Form Type | 8-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Prime Medicine filed an 8-K, but it's light on details.
AI Summary
Prime Medicine, Inc. filed an 8-K on March 18, 2025, reporting on other events and financial statements. The filing does not contain specific financial figures or details about the 'other events' beyond its classification.
Why It Matters
This 8-K filing indicates that Prime Medicine, Inc. has made a regulatory submission, but it lacks specific details on the nature of the events or financial information disclosed.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events and financial statements, with no immediate indication of significant risk or opportunity.
Key Players & Entities
- Prime Medicine, Inc. (company) — Registrant
- 0001193125-25-056122 (other) — Accession Number
- March 18, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- 60 First Street Cambridge, MA 02141 (address) — Principal Executive Offices
FAQ
What specific events are being reported in this 8-K filing by Prime Medicine, Inc.?
The filing indicates 'Other Events' and 'Regulation FD Disclosure' as items, but does not specify the nature of these events within the provided text.
When was this 8-K form filed by Prime Medicine, Inc.?
The 8-K form was filed on March 18, 2025.
What is the principal executive office address for Prime Medicine, Inc.?
The principal executive offices are located at 60 First Street, Cambridge, MA 02141.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the SIC code for Prime Medicine, Inc.?
The Standard Industrial Classification (SIC) code for Prime Medicine, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 18, 2025 regarding Prime Medicine, Inc. (PRME).